Posted on 4/23/19
UroGen Pharma Announces Early Stage Feasibility Agreement with Janssen
NEW YORK--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of uro-oncology, today announced that it has . . .
Posted on 4/23/19
Quest Diagnostics Reports First Quarter 2019 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2019."We're off . . .
Posted on 4/23/19
Stewart’s Ambulance Service/Transformative Healthcare Expands into 4 Maine and N.H. Seacoast Communities
MEREDITH, N.H.--(BUSINESS WIRE)--Stewart’s Ambulance Service is expanding into four Maine and New Hampshire Seacoast communities through new contracts to provide municipal 911 Emergency Medical Services (EMS) . . .
Posted on 4/23/19
IPO Update: Trevi Therapeutics Proposes IPO Terms
Summary Trevi Therapeutics has filed proposed terms for a $70 million IPO of its common stock. The firm is advancing programs led by its primary compound, . . .
Posted on 4/22/19
IBM Watson Health Names Nation's Top Health Systems
IBM Watson Health (NYSE: IBM) today published its 15 Top Health Systems annual study identifying top-performing health systems in the U.S. based on overall organizational performance. . . .
Posted on 4/22/19
Merck: Too Pricey Last Week, But In Range Today
SummaryMerck has had an amazing run-up in share price over the last 12 months.Merck has delivered outsized returns for shareholders who invested over the last 4 . . .
Posted on 4/22/19
Neurotrope Announces Inducement Grant to Newly-Appointed COO and General Counsel
Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases
Posted on 4/19/19
Rocket Pharmaceuticals Closes Public Offering
Rocket Pharmaceuticals, Inc. (Nasdaq:RCKT), a leading U.S.-based multi-platform gene therapy company, today announces the closing of its previously announced underwritten public offering of 5,175,000 shares of . . .
Posted on 4/18/19
Hookipa Pharma Debuts IPO
HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced the pricing . . .
Posted on 4/18/19
Actinium Pharmaceuticals Announces Pricing of $16.5 Million Public Offering of Common Stock and Warrants
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) today announced the pricing of an underwritten public offering of 42,860,000 shares of its common stock at a combined public . . .
Posted on 4/18/19
TB Alliance and Mylan Announce Global Collaboration
Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. (NASDAQ: MYL), today announced a global collaboration to make the experimental drug pretomanid accessible for use . . .
Posted on 4/18/19
Pfizer Ventures Leads $75M Series B For Arrakis Therapeutics
Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small-molecule medicines that directly target RNA, has completed a $75 million Series B
Posted on 4/18/19
Is TG Therapeutics a Buy?
TG Therapeutics (NASDAQ:TGTX), a clinical-stage hematology and autoimmune disease specialist, has been crushing the broader stock market this year. The biotech's shares surged higher in response . . .
Posted on 4/18/19
Here's Why Shares of bluebird bio Slumped Today
What happenedShares of bluebird bio (NASDAQ:BLUE) closed with a 9.5% drop on Wednesday, having been down as much as 10.3%, on no apparent news.So whatThe biotech . . .
Posted on 4/18/19
Actinium Pharmaceuticals Proposes Public Offering of Common Stock and Warrants
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that it intends to offer and sell, subject to market and other conditions, shares of its common . . .
Posted on 4/17/19
Tyto Care Partners With Best Buy
Tyto Care, creator of the health care industry's first all-in-one modular device and telehealth platform for on-demand, remote medical exams, is partnering with Best Buy to . . .
Posted on 4/17/19
2019’s Best & Worst States for Children’s Health Care – WalletHub Study
Raising a child in America is extremely expensive, costing the average parent over $230k, and health care accounts for a big chunk of the bill. And . . .
Posted on 4/17/19
Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition Closes
Sure, there was some drama along the way with Bristol-Myers Squibb's (NYSE:BMY)proposed acquisition of Celgene (NASDAQ:CELG). But it never made sense to bet against the deal. . . .
Posted on 4/17/19
Stock Market News: Johnson & Johnson Reports; AT&T Parts Ways With Hulu
U.S. stocks climbed on Tuesday morning following a bevy of better-than-expected earnings reports. As of 10:40 a.m. EDT, the Dow Jones Industrial Average (DJINDICES:^DJI) was up . . .
Posted on 4/17/19
Prognosis For The Medicines Company
SummaryWith the sale of its infectious disease assets in 2018, The Medicines Company has become a one-candidate company.Management indicated that its three pivotal Phase 3 trials . . .
Posted on 4/17/19
Johnson & Johnson (JNJ) Q1 2019 Earnings Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Johnson & Johnson (NYSE:JNJ)Q1 2019 Earnings CallApril 16, 2019, 8:30 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning, and welcome to . . .
Posted on 4/16/19
Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and . . .
Posted on 4/16/19
UnitedHealth Group Reports First Quarter 2019 Results
NEW YORK--(BUSINESS WIRE)--Strong, well-diversified performance continued across UnitedHealth Group (NYSE: UNH) in first quarter 2019.“Our employees’ shared vision of improving the health of the people we . . .
Posted on 4/16/19
Johnson & Johnson Reports 2019 First-Quarter Results
Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2019. "Our strong first-quarter results reflect continued underlying operational sales and adjusted EPS growth," said Alex . . .
Posted on 4/16/19
Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results
RUTHERFORD, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics, . . .

